Clozapine rechallenge after clozapine-induced myocarditis: A case report to validate a previously published protocol
Introduction Clozapine is an effective antipsychotic indicated for treatment-resistant schizophrenia (TRS). Its use is limited by its extensive adverse effect profile featuring rare but serious consequences like clozapine-induced myocarditis (CIM). In the event of CIM, clozapine is discontinued; how...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Association of Psychiatric Pharmacists
2025-10-01
|
| Schriftenreihe: | Mental Health Clinician |
| Schlagworte: | |
| Online-Zugang: | https://theijpt.org/doi/pdf/10.9740/mhc.2025.10.237 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|